Retention and patient engagement models for different treatment modalities in DATOS

Drug and Alcohol Dependence

Volumn 57, Issue 2, 1999, Pages 113-125

  Joe, George W ^a   Simpson, D Dwayne ^b   Broome, Kirk M ^b  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

^b NONE

Author keywords

DATOS; Motivation; Therapeutic engagements; Treatment process; Treatment retention

Indexed keywords

ALCOHOL; COCAINE; METHADONE;

ADULT; ALCOHOLISM; COCAINE DEPENDENCE; COUNSELING; CRIMINAL JUSTICE; DEPRESSION; DRUG DEPENDENCE TREATMENT; FEMALE; HUMAN; LAW; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; MODEL; MOTIVATION; OPIATE ADDICTION; OUTPATIENT; PRIORITY JOURNAL; RESIDENTIAL CARE; REVIEW; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0033485315     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0376-8716(99)00088-5     Document Type: Article

References (65)

1. Anglin M.D., Brecht M.L., Maddahian E. Pretreatment characteristics and treatment performance of legally coerced versus voluntary methadone maintenance admissions. Criminology. 27:1989;537-557.
2. Brecht M.L., Anglin M.D., Wang J.C. Treatment effectiveness for legally coerced versus voluntary methadone maintenance clients. Am. J. Drug Alcohol Abuse. 19:1993;89-106.
3. Broome K.M., Flynn P.M., Simpson D.D. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Services Res. 34:1999;791-806.
4. Broome K.M., Joe G.W., Simpson D.D. Patient and program attributes related to treatment process indicators in DATOS. Drug Alcohol Depend. 57(2):1999b;127-135.
5. Broome K.M., Knight K., Hiller M.L., Simpson D.D. Drug treatment process indicators for probationers and prediction of recidivism. J. Subst. Abuse Treat. 13:1996;487-491.
6. Brown B.S. AIDS and the provision of drug user treatment. Inter. J. Addict. 25:1991;1503-1514.
7. Condelli W.S., Fairbank J.A., Dennis M.L., Rachal J.V. Cocaine use by clients in methadone programs: significance, scope, and behavioral interventions. J. Subst. Abuse Treat. 8:1991;208-212.
8. Condelli W.S., Hubbard R.L. Relationship between time spent in treatment and client outcomes from therapeutic communities. J. Subst. Abuse Treat. 11:1994;25-33.
9. Dansereau D.F., Joe G.W., Simpson D.D. Node-link mapping: a visual representation strategy for enhancing drug abuse counseling. J. Counseling Psychol. 40:1993;385-395.
10. De Leon G. Integrative recovery: a stage paradigm. Subst. Abuse. 17:1996;51-63.
11. De Leon G., Jainchill N. Circumstance, motivation, readiness, and suitability as correlates of treatment tenure. J. Psychoactive Drugs. 18:1986;203-208.
12. Derogatis L.R., Lipman R.S., Covi L. The SCL-90: an outpatient psychiatric rating scale. Psychopharmacol. Bull. 9:1973;13-28.
13. Etheridge R.M., Craddock S.G., Hubbard R.L. The relationship of treatment and self-help participation to patient outcomes in DATOS. Drug Alcohol Depend. 57(2):1999;99-112.
14. Fiorentine R., Anglin M.D. More is better: counseling participation and the effectiveness of outpatient drug treatment. J. Subst. Abuse Treat. 7:1996;341-348.
15. Fiorentine R., Anglin M.D. Does increasing the opportunity for counseling increase the effectiveness of outpatient drug treatment? Am. J. Drug Alcohol Abuse. 23:1997;369-382.
16. Fletcher B.W., Tims F.M., Brown B.S. Drug Abuse Treatment Outcome Study (DATOS): treatment evaluation research in the United States. Psychol. Addict. Behav. 11:1997;216-229.
17. Flynn P.M., Craddock S.G., Hubbard R.L., Anderson J., Etheridge R.M. Methodological overview and research design for the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 11:1997;230-243.
18. Gossop M., Marsden J., Stewart D., Rolfe A. Treatment retention and one year outcomes for residential programmes in England. Drug Alcohol Depend. 57(2):1999;89-98.
19. Grella C., Hser Y., Joshi V., Anglin M.D. Patient histories, retention, and outcome models for younger and older adults in DATOS. Drug Alcohol Depend. 57(2):1999;151-160.
20. Hiller M.L., Knight K., Broome K.M., Simpson D.D. Legal pressure and treatment retention in a national sample of long-term residential programs. Crim. Just. Behav. 25:1998;463-481.
21. Hoffman J.A., Moolchan E.T. The phases-of-treatment model for methadone maintenance: implementation and evaluation. J. Psychoactive Drugs. 26:1994;181-197.
22. Horvath A.O., Greenberg L.S. The development of the Working Alliance Inventory. Greenberg L., Pinsof W. The Psychotherapeutic Process: A Resource Handbook. 1986;529-556 Guilford Press, New York.
23. Hser Y. Drug treatment counselor practices and effectiveness. Eval. Rev. 19:1995;389-408.
24. Hser Y., Anglin M.D., Grella C.E., Longshore D., Prendergast M.L. Drug treatment careers: a conceptual framework and existing research findings. J. Subst. Abuse Treat. 14:1997;543-558.
25. Hser Y., Grella C., Chou C., Anglin M.D. Relationships between drug treatment careers and outcomes. Eval. Rev. 22:1998;496-519.
26. Hser Y., Grella C., Hsieh S., Anglin M.D., Brown B. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 57(2):1999;137-150.
27. Hubbard R.L., Craddock S.G., Flynn P.M., Anderson J., Etheridge R.M. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 11:1997;261-278.
28. Hubbard R.L., Marsden M.E., Cavanaugh E.R., Rachal J.V., Ginzburg H.M. Role of Drug Abuse Treatment in limiting the spread of AIDS. Rev. Infect. Dis. 10:1988;377-384.
29. Hubbard R.L., Marsden M.E., Rachal J.V., Harwood H.J., Cavanaugh E.R., Ginzburg H.M. Drug Abuse Treatment: a National Study of Effectiveness. 1989;University of North Carolina Press, Chapel Hill.
30. Hunt D.E., Strug D.L., Goldsmith D.S., Lipton D.S., Spunt B., Truitt L. et al. An instant shot of 'aah': cocaine use among methadone clients. J. Psychoactive Drugs. 16:1984;217-227.
31. Joe G.W., Brown B.S., Simpson D.D. Psychological problems and engagement in treatment. J. Nerv. Men. Dis. 183:1995;704-710.
32. Joe G.W., Dansereau D.F., Simpson D.D. Node-link mapping for counseling cocaine users in methadone treatment. J. Subst. Abuse. 6:1994;393-406.
33. Joe G.W., Simpson D.D. Retention in treatment of drug users: 1971-1972 DARP admissions. Am. J. Drug Alcohol Abuse. 2:1975;63-71.
34. Joe G.W., Simpson D.D., Broome K.M. Effects of readiness for drug abuse treatment on client retention and assessment of process. Addiction. 93:1998;1177-1190.
35. Joe G.W., Simpson D.D., Hubbard R.L. Treatment predictors of tenure in methadone maintenance. J. Subst. Abuse. 3:1991;73-84.
36. Jöreskog K.G., Sörbom D. LISREL 8: Structural Equation Modeling with the SIMPLIS Command Language. 1993;Lawrence Erlbaum, Hillsdale, NJ.
37. Keeping E.S. Introduction to Statistical Inference. 1962;D Van Nostrand, Inc, Princeton, NJ.
38. Kosten T.R., Rounsaville B.J., Kleber H.D. A 2.5 year follow-up of cocaine use among treated opioid addicts: have our treatments helped? Arch. Gen. Psychiatry. 44:1987;281-284.
39. MacGowan R.J., Swanson N.M., Brackbill R.M., Rugg D.L., Barker T., Molde S. Retention in methadone maintenance treatment programs, Connecticut and Massachusetts, 1990-1993. J. Psychoactive Drugs. 28:1996;259-265.
40. McLellan A.T., Woody G.E., Luborsky L., O'Brien C.P., Druley K.A. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch. Gen. Psychiatry. 40:1983;620-625.
41. Miller W.R., Rollnick S. Motivational Interviewing: Preparing People to Change Addictive Behavior. 1991;Guilford Press, New York.
42. Moolchan E.T., Hoffman J.A. Phases of treatment: a practical approach to methadone maintenance treatment. Inter. J. Addict. 29:1994;135-160.
43. Orlinsky D.E., Howard K.I. A generic model of psychotherapy. J. Integr. Eclectic Psychother. 6:1987;6-27.
44. Prochaska J.O., DiClemente C.C., Norcross J.C. In search of how people change: applications to addictive behaviors. Am. Psychol. 47:1992;1102-1114.
45. Rawson R.A., Obert J.L., McCann M.J., Marinelli-Casey P. Relapse prevention models for substance abuse treatment. Psychotherapy. 30:1993;284-298.
46. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. National Institute of Mental Health diagnostic interview schedule. Arch. Gen. Psychiatry. 38:1981;381-389.
47. Robins L.N., Wing J.K., Helzer J.E. Composite International Diagnostic Interview (CIDI). 1983;World Health Organization, Geneva, Switzerland.
48. Rounsaville B.J., Tierney T., Crits-Christoph K., Weissman M.M., Kleber H.D. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Comp. Psychiatry. 23:1982;462-478.
49. Rowan-Szal G.A., Joe G.W., Hiller M.L., Simpson D.D. Increasing early engagement in methadone treatment. J. Maintenance Addict. 1:1997;49-61.
50. Rowan-Szal, G.A., Joe, G.W., Simpson, D.D., in press. Treatment retention of crack and cocaine users in a national sample of long term residential clients. Addict. Res.
51. Simpson D.D. The relation of time spent in drug abuse treatment to posttreatment outcomes. Am. J. Psychiatry. 136:1979;1449-1453.
52. Simpson D.D. Treatment for drug abuse: follow-up outcomes and length of time spent. Arch. Gen. Psychiatry. 38:1981;875-880.
53. Simpson D.D. Effectiveness of drug abuse treatment: a review of research from field settings. Egertson J.A., Fox D.M., Leshner A.I. Treating Drug Abusers Effectively. 1997;Blackwell Publishers of North America, Cambridge, MA.
54. Simpson, D.D., Curry, S.J. (Eds.), 1997. Drug Abuse Treatment Outcome Study (DATOS), (special issue). Psychol. Addict. Behav. 11.
55. Simpson D.D., Joe G.W. Motivation as a predictor of early dropout from drug abuse treatment. Psychotherapy. 30:1993;357-368.
56. Simpson, D.D., Joe, GW., 1998. An emerging conceptual model for effective drug abuse treatment. Manuscript under revision.
57. Simpson D.D., Joe G.W., Broome K.M., Hiller M.L., Knight K., Rowan-Szal G.A. Program diversity and treatment retention rates in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 11:1997;279-293.
58. Simpson D.D., Joe G.W., Brown B.S. Treatment retention and follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychol. Addict. Behav. 11:1997;294-307.
59. Simpson D.D., Joe G.W., Dansereau D.F., Chatham L.R. Strategies for improving methadone treatment process and outcomes. J. Drug Issues. 27:1997;239-260.
60. Simpson D.D., Joe G.W., Fletcher B.W., Hubbard R.L., Anglin M.D. A national evaluation of treatment outcomes for cocaine dependence. Arch. Gen. Psychiatry. 56:1999;507-514.
61. Simpson, D.D., Joe, G.W., Greener, J.M., Rowan-Szal, G.A., in press. Modeling year 1 outcomes with treatment process and posttreatment social influences. Subst. Use Misuse.
62. Simpson D.D., Joe G.W., Rowan-Szal G.A. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend. 47:1997;227-235.
63. Simpson D.D., Joe G.W., Rowan-Szal G., Greener J. Client engagement and change during drug abuse treatment. J. Subst. Abuse. 7:1995;117-134.
64. Simpson D.D., Joe G.W., Rowan-Szal G.A., Greener J.M. Drug abuse treatment process components that improve retention. J. Subst. Abuse Treat. 14:1997;565-572.
65. Woody G.E., McLellan A.T., Luborsky L., O'Brien C.P., Blaine J., Fox S. et al. Severity of psychiatric symptoms as a predictor of benefits from psychotherapy: the Veterans Administration-Penn study. Am. J. Psychiatry. 141:1984;1172-1177.